TY - GEN
T1 - Contrast-enhanced brain MRI synthesis with deep learning
T2 - 18th IEEE International Symposium on Biomedical Imaging, ISBI 2021
AU - Bone, Alexandre
AU - Ammari, Samy
AU - Lamarque, Jean Philippe
AU - Elhaik, Mickael
AU - Chouzenoux, Emilie
AU - Nicolas, Francois
AU - Robert, Philippe
AU - Balleyguier, Corinne
AU - Lassau, Nathalie
AU - Rohe, Marc Michel
N1 - Publisher Copyright:
© 2021 IEEE.
PY - 2021/4/13
Y1 - 2021/4/13
N2 - Contrast-enhanced medical images offer vital insights for the accurate diagnosis, characterization and treatment of tumors, and are routinely used worldwide. Acquiring such images requires to inject the patient intravenously with a gadolinium-based contrast agent (GBCA). Although GBCAs are considered safe, recent concerns about their accumulation in the body tilted the medical consensus towards a more parsimonious usage. Focusing on the case of brain magnetic resonance imaging, this paper proposes a deep learning method that synthesizes virtual contrast-enhanced T1 images as if they had been acquired after the injection of a standard 0.100mmol/kg dose of GBCA, taking as inputs complementary imaging modalities obtained either after a reduced injection at 0.025mmol/kg or without any GBCA involved. The method achieves a competitive structural similarity index of 94.2%. Its asymptotic performance is estimated, and the most important input modalities are identified.
AB - Contrast-enhanced medical images offer vital insights for the accurate diagnosis, characterization and treatment of tumors, and are routinely used worldwide. Acquiring such images requires to inject the patient intravenously with a gadolinium-based contrast agent (GBCA). Although GBCAs are considered safe, recent concerns about their accumulation in the body tilted the medical consensus towards a more parsimonious usage. Focusing on the case of brain magnetic resonance imaging, this paper proposes a deep learning method that synthesizes virtual contrast-enhanced T1 images as if they had been acquired after the injection of a standard 0.100mmol/kg dose of GBCA, taking as inputs complementary imaging modalities obtained either after a reduced injection at 0.025mmol/kg or without any GBCA involved. The method achieves a competitive structural similarity index of 94.2%. Its asymptotic performance is estimated, and the most important input modalities are identified.
KW - Brain MRI
KW - Gadolinium-based contrast agents (GBCA)
KW - Low-dose imaging
KW - Virtual enhancement
UR - http://www.scopus.com/inward/record.url?scp=85107179164&partnerID=8YFLogxK
U2 - 10.1109/ISBI48211.2021.9434029
DO - 10.1109/ISBI48211.2021.9434029
M3 - Conference contribution
AN - SCOPUS:85107179164
T3 - Proceedings - International Symposium on Biomedical Imaging
SP - 1159
EP - 1163
BT - 2021 IEEE 18th International Symposium on Biomedical Imaging, ISBI 2021
PB - IEEE Computer Society
Y2 - 13 April 2021 through 16 April 2021
ER -